Market Place
Sourcing Support
All News #Library
Sciences
Hal Barron’s GSK team continues to cull resp drugs in big shift to oncology R&D
06 Feb 2019 //
ENDPTS
GSK looks to oncology for growth as Advair generic hits
06 Feb 2019 //
FIERCE PHARMA
First-line ovarian approval cements AZ’s Lynparza lead
20 Dec 2018 //
PM LIVE
Clovis should put itself up for sale, activist Armistice says: report
19 Dec 2018 //
FIERCE PHARMA
Will Clovis be the next PARP maker to get swallowed up?
08 Dec 2018 //
FIERCE PHARMA
AstraZeneca`s Lynparza shown to put brakes on ovarian cancer
23 Oct 2018 //
REUTERS
Newly discovered ALS mechanism could point the way to novel drugs
06 Sep 2018 //
FIERCE BIOTECH
PARP inhibitors for ALS? Penn researchers post promising finds in brain disease
10 Aug 2018 //
ENDPTS
Cha-ching: Small biotechs write some of America`s biggest paychecks
07 Aug 2018 //
FIERCE PHARMA
Could even more cancer patients benefit from PARP inhibitors?
16 Jul 2018 //
FIERCE BIOTECH
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.